Argoncillo, Gloria L.
HRN: 15-95-37 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/21/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/21/2025
01/28/2025
IV
600mg
Every 6 Hours
Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes